Lynch Ryan Insider Trades & Stock Holdings
Lynch Ryan, Treasurer, Senior Vice President of Finance and Chief Accounting Officer. at Crescent Biopharma, Inc. has 1 Form 4 trade on file since Sep 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($4.30K), net -$4.30K. Latest filing: disposed of 240 shares of $CBIO on Sep 16, 2026 at $17.90.
- Trades on file
- 1
- Open-market bought
- $0
- Open-market sold
- $4.30K
- Net open-market
- -$4.30K
- Latest filing
- Sep 16, 2026
All insider trades by Lynch Ryan
| Date | Ticker | Type | Shares | Price | Value | Owned after | ΔOwn | 1W | 1M | 6M | Role | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $CBIO | Sell (Open-market sale) 10b5-1 | 240 | $17.90 | $4.30K | Treasurer, Senior Vice President of Finance and Chief Accounting Officer. | — |
"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.
Stocks Lynch Ryan traded
Frequently asked questions
Has Lynch Ryan been buying or selling stock?
Lynch Ryan has 0 open-market purchases and 1 open-market sale on file, net -$4.30K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.
What was Lynch Ryan's latest insider trade?
disposed of 240 shares of $CBIO on Sep 16, 2026 at $17.90.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.